Boston Scientific
471 hedge funds and large institutions have $21.3B invested in Boston Scientific in 2015 Q1 according to their latest regulatory filings, with 73 funds opening new positions, 141 increasing their positions, 187 reducing their positions, and 51 closing their positions.
43% more first-time investments, than exits
New positions opened: 73 | Existing positions closed: 51
38% more funds holding in top 10
Funds holding in top 10: 8 → 11 (+3)
34% more capital invested
Capital invested by funds: $15.9B → $21.3B (+$5.43B)
3% more funds holding
Funds holding: 457 → 471 (+14)
0.63% less ownership
Funds ownership: 90.48% → 89.85% (-0.63%)
25% less repeat investments, than reductions
Existing positions increased: 141 | Existing positions reduced: 187
28% less call options, than puts
Call options by funds: $57.7M | Put options by funds: $80.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$208M |
| 2 |
O
OppenheimerFunds
New York
|
+$123M |
| 3 |
Bank of New York Mellon
New York
|
+$117M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$109M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$84.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$214M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$158M |
| 3 |
Axa
Paris,
France
|
-$125M |
| 4 |
Two Sigma Investments
New York
|
-$91.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$46.5M |
BSX Hedge Fund Activity: Q1 2015 in Review
471 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2015, worth a combined $21.3B — up 34% from $15.9B a quarter earlier.
Buyers outnumbered sellers: 73 funds opened new BSX positions and 51 closed out — a net gain of 22 holders — while 141 added to existing stakes and 187 trimmed.
The largest buyer was OrbiMed, adding an estimated $208M. The largest seller was JP Morgan Chase, cutting an estimated $214M.
- 471 institutional investors held Boston Scientific (BSX) as of Q1 2015, up from 457 in Q4 2014.
- Funds reported $21.3B of Boston Scientific stock for Q1 2015, up 34% quarter-over-quarter.
- 73 funds opened new Boston Scientific positions in Q1 2015 and 51 closed out, a net change of +22 holders.
- The largest Boston Scientific buyer in Q1 2015 was OrbiMed, an estimated $208M added.
- The largest Boston Scientific seller in Q1 2015 was JP Morgan Chase, an estimated $214M sold.
Based on aggregated 13F filings for Q1 2015.